A number of other equities research analysts have also recently weighed in on the company. Stifel Nicolaus cut their price target on IntriCon from $70.00 to $45.00 and set a buy rating on the stock in a report on Friday, January 4th. Zacks Investment Research cut IntriCon from a buy rating to a hold rating in a report on Friday, January 4th. Dougherty & Co raised IntriCon from a neutral rating to a buy rating and set a $44.00 target price on the stock in a report on Thursday, January 3rd. Finally, BidaskClub cut IntriCon from a buy rating to a hold rating in a report on Wednesday, December 12th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of $50.25.
IIN stock traded up $0.27 during midday trading on Friday, reaching $26.67. The company had a trading volume of 117,180 shares, compared to its average volume of 166,485. The company has a market cap of $229.72 million, a P/E ratio of 41.67, a PEG ratio of 3.27 and a beta of 1.21. IntriCon has a fifty-two week low of $20.95 and a fifty-two week high of $76.80.
In other IntriCon news, VP Greg Gruenhagen sold 4,500 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $26.87, for a total value of $120,915.00. Following the transaction, the vice president now owns 7,662 shares of the company’s stock, valued at $205,877.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders sold 7,500 shares of company stock worth $198,225 in the last ninety days. 11.50% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. MetLife Investment Advisors LLC purchased a new position in IntriCon during the 3rd quarter worth approximately $295,000. Shell Asset Management Co. purchased a new position in shares of IntriCon during the 3rd quarter valued at $310,000. Sun Life Financial INC purchased a new position in shares of IntriCon during the 4th quarter valued at $155,000. Russell Investments Group Ltd. purchased a new position in shares of IntriCon during the 3rd quarter valued at $348,000. Finally, Alliancebernstein L.P. purchased a new position in shares of IntriCon during the 3rd quarter valued at $393,000. Hedge funds and other institutional investors own 64.83% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Article: Leveraged Buyout (LBO)
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.